McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
McKesson, News Corporation And 2 Other Stocks Executives Are Selling
The Nasdaq 100 closed lower by over 500 points during Friday's session. Investors, meanwhile, focused on some notable insider trades.
McKesson Shares Fall Following Sale of Rexall, Well.ca to Birch Hill
MCK announces the sale of its Canada-based Rexall and Well.ca businesses to Birch Hill Equity Partners, aligning with its strategy to grow oncology and biopharma services.
S&P 500 Gains and Losses Today: McKesson Falls Amid Plans To Exit Canada Businesses
Major U.S. equities indexes were mixed as the latest ADP jobs data showed a smaller-than-expected jump in private payrolls in August.
Drug distributor McKesson forecasts Q2 profit below estimates
Drug distributor McKesson on Thursday forecast second-quarter profit below Wall Street estimates.
McKesson Corporation (MCK) Wells Fargo 2024 Healthcare Conference (Transcript)
McKesson Corporation (NYSE:MCK ) Wells Fargo 2024 Healthcare Conference September 5, 2024 8:45 AM ET Company Participants Britt Vitalone - Executive Vice President and Chief Financial Officer Conference Call Participants Stephen Baxter - Wells Fargo Stephen Baxter Good morning. I'm Steve Baxter, the Healthcare Services Analyst at Wells Fargo.
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
McKesson (MCK) Upgraded to Buy: Here's Why
McKesson (MCK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Should Value Investors Buy McKesson (MCK) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Wall Street Analysts See McKesson (MCK) as a Buy: Should You Invest?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
MCK Stock's Uptrend Likely to Continue After Core Ventures Acquisition
McKesson's agreement to acquire a controlling interest will likely bring advanced treatments and improved care experiences to patients.
Drug distributor McKesson to buy controlling stake in Core Ventures for about $2.5 bln
Drug distributor McKesson said on Monday it would buy a controlling stake in community cancer center Florida Cancer Specialists & Research Institute's business and administrative services unit, Core Ventures, for $2.49 billion in cash.
